Dated values
MarkdownProposed CHP regulation consultation and migration timeline
Traditional Chinese medicinal products are described as subject to a separate framework from early 2027; consultation proposals are not themselves enacted law.
Consultation 1–29 July 2026; HSA intends to move remaining CHP medicinal-product controls from the Medicines Act to the Health Products Act by end-2028 consultation window and proposed policy timeline
- Reference period
- HSA consultation notice dated 1 July 2026
- Population
- Complementary health products in the consulted scope, including health supplements, specified traditional medicines, homeopathic medicines, medicated oils, balms, plasters and topical antiseptics
- Denominator
- Proposed framework and consultation scope; not enacted obligations for every product or final implementation rules
- Geography
- Singapore
Record details
- Published
- 2026-07-01
- Metric
- proposed chp regulation 2026 consultation
- Source revision
- HSA proposed CHP regulatory framework consultation
Dates describe this record’s own period and applicability. A verification date does not mean a rule is currently in force.
Sources
Collection as of 2026-11-22 · An expanding collection. Published counts show available knowledge, not complete coverage of Singapore.
Machine-readable: JSON · sgobs.consumer.proposed-chp-regulation-2026.consultation